| Andrea Fraley, MD | |
|
2017 W I 35 Frontage Rd, Suite 130, Edmond, OK 73013-8504 | |
| (405) 757-3630 | |
| (405) 757-3631 |
| Full Name | Andrea Fraley |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 22 Years |
| Location | 2017 W I 35 Frontage Rd, Edmond, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487660585 | NPI | - | NPPES |
| 036115728 | Medicaid | IL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stillwater Medical Center | Stillwater, OK | Hospital |
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stillwater Medical Center Authority | 2365353794 | 143 |
| Fraley Clinic Pllc | 5294001962 | 2 |
News Archive
Use of bioprosthetic heart valves has dramatically increased (from 18% in 1991 to 59% in 2003), mainly in older patients with comorbidities. This is due to the increased risk of bleeding complications associated with lifelong use of anticoagulation for mechanical prostheses.
Researchers led by the epidemiologist Elise Tessier, of Public Health England, have been investigating the proportion of unvaccinated individuals against coronavirus disease 2019 (COVID-19) by age, sex, location, vaccine type, ethnicity and poverty level in the United Kingdom.
Cytovance Biologics LLC, a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture, today announced the addition of Dr. Jeffrey Su as Vice President of Bioanalytical Development to its diverse and growing scientific staff. Dr. Su will head up the state of the art Bioanalytical Development laboratory supporting existing and new client needs.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
› Verified 8 days ago
| Entity Name | Stillwater Medical Center Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558377135 PECOS PAC ID: 2365353794 Enrollment ID: O20040525001304 |
News Archive
Use of bioprosthetic heart valves has dramatically increased (from 18% in 1991 to 59% in 2003), mainly in older patients with comorbidities. This is due to the increased risk of bleeding complications associated with lifelong use of anticoagulation for mechanical prostheses.
Researchers led by the epidemiologist Elise Tessier, of Public Health England, have been investigating the proportion of unvaccinated individuals against coronavirus disease 2019 (COVID-19) by age, sex, location, vaccine type, ethnicity and poverty level in the United Kingdom.
Cytovance Biologics LLC, a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture, today announced the addition of Dr. Jeffrey Su as Vice President of Bioanalytical Development to its diverse and growing scientific staff. Dr. Su will head up the state of the art Bioanalytical Development laboratory supporting existing and new client needs.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
› Verified 8 days ago
| Entity Name | Fraley Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568985182 PECOS PAC ID: 5294001962 Enrollment ID: O20171024002964 |
News Archive
Use of bioprosthetic heart valves has dramatically increased (from 18% in 1991 to 59% in 2003), mainly in older patients with comorbidities. This is due to the increased risk of bleeding complications associated with lifelong use of anticoagulation for mechanical prostheses.
Researchers led by the epidemiologist Elise Tessier, of Public Health England, have been investigating the proportion of unvaccinated individuals against coronavirus disease 2019 (COVID-19) by age, sex, location, vaccine type, ethnicity and poverty level in the United Kingdom.
Cytovance Biologics LLC, a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture, today announced the addition of Dr. Jeffrey Su as Vice President of Bioanalytical Development to its diverse and growing scientific staff. Dr. Su will head up the state of the art Bioanalytical Development laboratory supporting existing and new client needs.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Fraley, MD 925 W I 35 Frontage Rd Ste 100, Edmond, OK 73034-7399 Ph: (405) 471-5460 | Andrea Fraley, MD 2017 W I 35 Frontage Rd, Suite 130, Edmond, OK 73013-8504 Ph: (405) 757-3630 |
News Archive
Use of bioprosthetic heart valves has dramatically increased (from 18% in 1991 to 59% in 2003), mainly in older patients with comorbidities. This is due to the increased risk of bleeding complications associated with lifelong use of anticoagulation for mechanical prostheses.
Researchers led by the epidemiologist Elise Tessier, of Public Health England, have been investigating the proportion of unvaccinated individuals against coronavirus disease 2019 (COVID-19) by age, sex, location, vaccine type, ethnicity and poverty level in the United Kingdom.
Cytovance Biologics LLC, a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture, today announced the addition of Dr. Jeffrey Su as Vice President of Bioanalytical Development to its diverse and growing scientific staff. Dr. Su will head up the state of the art Bioanalytical Development laboratory supporting existing and new client needs.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
› Verified 8 days ago
Caroline Swayne, COTA/L Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 307 E Danforth Rd Ste 130, Edmond, OK 73034 Phone: 405-397-3550 | |
Mrs. Leah Lynnette Emerson, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1 S Bryant Ave, Edmond, OK 73034 Phone: 405-538-7820 | |
Katie Ann Walker, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4350 Strawberry Ln, Edmond, OK 73034 Phone: 580-774-8657 | |
Ms. Michelle Lea Krause, PT/ATC Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2501 E Memorial Rd, Edmond, OK 73013 Phone: 405-425-1960 Fax: 405-425-1962 |